Experimental Treatment of Ebola Virus Disease with Brincidofovir

Hdl Handle:
http://hdl.handle.net/10144/618652
Title:
Experimental Treatment of Ebola Virus Disease with Brincidofovir
Authors:
Dunning, J; Kennedy, SB; Antierens, A; Whitehead, J; Ciglenecki, I; Carson, G; Kanapathipillai, R; Castle, L; Howell-Jones, R; Pardinaz-Solis, R; Grove, J; Scott, J; Lang, T; Olliaro, P; Horby, PW
Journal:
PloS One
Abstract:
The nucleotide analogue brincidofovir was developed to prevent and treat infections caused by double-stranded DNA viruses. Based on in vitro data suggesting an antiviral effect against Ebola virus, brincidofovir was included in the World Health Organisation list of agents that should be prioritised for clinical evaluation in patients with Ebola virus disease (EVD) during the West African epidemic.
Publisher:
Public Library of Science
Issue Date:
9-Sep-2016
URI:
http://hdl.handle.net/10144/618652
DOI:
10.1371/journal.pone.0162199
PubMed ID:
27611077
Submitted date:
2016-09-12
Language:
en
ISSN:
1932-6203
Appears in Collections:
Other Diseases

Full metadata record

DC FieldValue Language
dc.contributor.authorDunning, Jen
dc.contributor.authorKennedy, SBen
dc.contributor.authorAntierens, Aen
dc.contributor.authorWhitehead, Jen
dc.contributor.authorCiglenecki, Ien
dc.contributor.authorCarson, Gen
dc.contributor.authorKanapathipillai, Ren
dc.contributor.authorCastle, Len
dc.contributor.authorHowell-Jones, Ren
dc.contributor.authorPardinaz-Solis, Ren
dc.contributor.authorGrove, Jen
dc.contributor.authorScott, Jen
dc.contributor.authorLang, Ten
dc.contributor.authorOlliaro, Pen
dc.contributor.authorHorby, PWen
dc.date.accessioned2016-09-15T15:09:39Z-
dc.date.available2016-09-15T15:09:39Z-
dc.date.issued2016-09-09-
dc.date.submitted2016-09-12-
dc.identifier.citationExperimental Treatment of Ebola Virus Disease with Brincidofovir., 11 (9):e0162199 PLoS ONEen
dc.identifier.issn1932-6203-
dc.identifier.pmid27611077-
dc.identifier.doi10.1371/journal.pone.0162199-
dc.identifier.urihttp://hdl.handle.net/10144/618652-
dc.description.abstractThe nucleotide analogue brincidofovir was developed to prevent and treat infections caused by double-stranded DNA viruses. Based on in vitro data suggesting an antiviral effect against Ebola virus, brincidofovir was included in the World Health Organisation list of agents that should be prioritised for clinical evaluation in patients with Ebola virus disease (EVD) during the West African epidemic.en
dc.languageENG-
dc.language.isoenen
dc.publisherPublic Library of Scienceen
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen
dc.titleExperimental Treatment of Ebola Virus Disease with Brincidofoviren
dc.identifier.journalPloS Oneen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.